Magle Chemoswed Holding AB has signed a binding term sheet to acquire all shares in pK Biotech ApS and its subsidiary pK Chemicals A/S from PRS1 ApS (the "Seller"). This combination will significantly expand Magle Group?s contract development and manufacturing organisation (CDMO) capabilities, increasing production capacity and broadening service offerings to meet the growing demand for high-quality development and manufacturing services.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.4 SEK | -4.27% | -0.98% | +60.32% |
Jun. 28 | Magle Chemoswed Finalizes Agreement for pK Chemicals, pK Biotech Acquisition | MT |
Jun. 17 | Magle Chemoswed Holding AB Announces Increasing Production Capacity | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.32% | 41.43M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- MAGLE Stock
- News Magle Chemoswed Holding AB
- Magle Chemoswed Holding AB Announces Increasing Production Capacity